Indivior (NASDAQ:INDV) Stock Price Down 4.7% – Time to Sell?

Indivior PLC (NASDAQ:INDV)’s share price dropped 4.7% during mid-day trading on Wednesday . The company traded as low as $10.92 and last traded at $10.86. Approximately 350,553 shares traded hands during trading, a decline of 68% from the average daily volume of 1,104,098 shares. The stock had previously closed at $11.40.

Analyst Ratings Changes

Several research analysts have commented on the stock. Piper Sandler restated an “overweight” rating and issued a $16.00 target price (up previously from $15.00) on shares of Indivior in a research report on Friday, October 25th. Rodman & Renshaw assumed coverage on Indivior in a report on Tuesday, January 28th. They issued a “buy” rating and a $16.00 price objective for the company. RODMAN&RENSHAW raised Indivior to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Craig Hallum decreased their price target on Indivior from $20.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, October 11th.

Indivior Price Performance

The firm has a market capitalization of $1.32 billion, a P/E ratio of -239.44 and a beta of 0.74. The firm’s fifty day moving average price is $11.80 and its 200-day moving average price is $11.06.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of INDV. Amundi lifted its holdings in Indivior by 12.2% in the 4th quarter. Amundi now owns 174,434 shares of the company’s stock valued at $2,109,000 after acquiring an additional 19,010 shares during the last quarter. Clark Estates Inc. NY grew its position in Indivior by 1.3% in the fourth quarter. Clark Estates Inc. NY now owns 257,400 shares of the company’s stock worth $3,199,000 after buying an additional 3,300 shares during the last quarter. VELA Investment Management LLC increased its holdings in shares of Indivior by 45.5% in the fourth quarter. VELA Investment Management LLC now owns 179,659 shares of the company’s stock valued at $2,264,000 after buying an additional 56,224 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Indivior during the 4th quarter valued at $56,000. Finally, China Universal Asset Management Co. Ltd. bought a new stake in shares of Indivior during the 4th quarter worth $359,000. 60.33% of the stock is owned by institutional investors and hedge funds.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.